Syqe Medical aims to transform cannabis and other psychoactive botanicals into mainstream medical drugs.
Syqe Medical has raised €44M across 1 funding round from 3 investors, most recently a round in Jan 2019. Based in Tel Aviv, Israel; founded 2011; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Other | €44M |
| Martin Bauer Group,PRM Holdings Fund,Shavit Capital fund |
| View deal → |
